3D Global Biotech Inc.
6808.TWO
Price:
$49.85
Market Cap:
$3.78B
3D Global Biotech Inc. develops medical materials for human body reconstruction in China. It uses cell culture systems, 3D printing technology, and bio-inks hydrogel as the basis to develop and produce customized autologous cell-based medical products. The company develops human tissue and organ reconstruction platforms; develops customized and personalized medical equipment; and conducts professional research. It offers artificial bone substitute, skull fixation system, biological dressings, bio inks, and bioprinting equipment, as well as orthopedic, tooth and jaw, and skull reconstruction products, and scalp care products. It serves medical centers, research institutions, and companies and...[Read more]
Industry
Biotechnology
IPO Date
2020-12-25
Stock Exchange
TWO
Ticker
6808.TWO
PE Ratio
[27.09]
ROE
[14.79%]
Current Ratio
[11.34]
Dividend Yield
[1.06%]
Enterprise Value
[3.81B]
Dividend History
The ROE as of December 2025 (TTM) for 3D Global Biotech Inc. (6808.TWO) is 14.79%
According to 3D Global Biotech Inc.’s latest financial reports and current stock price. The company's current ROE is 14.79%. This represents a change of 1.09% compared to the average of 1.25% of the last 4 quarters.
3D Global Biotech Inc. (6808.TWO) Historical ROE (quarterly & annually)
How has 6808.TWO ROE performed in the past?
The mean historical ROE of 3D Global Biotech Inc. over the last ten years is -10.46%. The current 14.79% ROE has changed -241.48% with respect to the historical average. Over the past ten years (40 quarters), 6808.TWO's ROE was at its highest in in the December 2024 quarter at 10.33%. The ROE was at its lowest in in the December 2022 quarter at -10.07%.
Average
-10.46%
Median
-13.00%
Minimum
-19.75%
Maximum
10.14%
3D Global Biotech Inc. (6808.TWO) ROE by Quarter and Year
Discovering the peaks and valleys of 3D Global Biotech Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 43.76%
Maximum Annual ROE = 10.14%
Minimum Annual Increase = -151.33%
Minimum Annual ROE = -19.75%
| Year | ROE | Change |
|---|---|---|
| 2024 | 10.14% | -151.33% |
| 2023 | -19.75% | 0.26% |
| 2022 | -19.70% | 28.56% |
| 2021 | -15.32% | 43.50% |
| 2020 | -10.68% | 43.76% |
3D Global Biotech Inc. (6808.TWO) Average ROE
How has 6808.TWO ROE performed in the past?
The current ROE of 3D Global Biotech Inc. (6808.TWO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-9.77%
5-year avg
-11.06%
10-year avg
-10.46%
3D Global Biotech Inc. (6808.TWO) ROE vs. Peers
How is 6808.TWO’s ROE compared to its peers?
3D Global Biotech Inc.’s ROE is less than Syngen Biotech Co.,Ltd. (12.66%), less than Synbio Tech Inc. (16.47%), less than SYN-TECH Chem. & Pharm. Co., Ltd. (12.18%), less than Apex Biotechnology Corp. (9.07%), less than G&E Herbal Biotechnology Co., Ltd. (15.97%), greater than TWi Biotechnology, Inc. (-69.83%), greater than Shine-On BioMedical Co.,Ltd. (-11.76%), greater than Sagittarius Life Science Corp (-9.31%), greater than BRIM Biotechnology, Inc. (-11.90%), greater than Energenesis Biomedical CO.,LTD. (-32.50%),
| Company | ROE | Market cap |
|---|---|---|
| 12.66% | $3.46B | |
| 16.47% | $3.25B | |
| 12.18% | $3.39B | |
| 9.07% | $3.14B | |
| 15.97% | $3.01B | |
| -69.83% | $2.04B | |
| -11.76% | $3.54B | |
| -9.31% | $3.23B | |
| -11.90% | $3.70B | |
| -32.50% | $3.81B |
Build a custom stock screener for 3D Global Biotech Inc. (6808.TWO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 3D Global Biotech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
3D Global Biotech Inc. (6808.TWO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like 3D Global Biotech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is 3D Global Biotech Inc.'s ROE?
How is the ROE calculated for 3D Global Biotech Inc. (6808.TWO)?
What is the highest ROE for 3D Global Biotech Inc. (6808.TWO)?
What is the 3-year average ROE for 3D Global Biotech Inc. (6808.TWO)?
What is the 5-year average ROE for 3D Global Biotech Inc. (6808.TWO)?
How does the current ROE for 3D Global Biotech Inc. (6808.TWO) compare to its historical average?